Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...
Jun 5 1997
WASHINGTON, D.C.-----Eleven international biotechnology organizations have endorsed the Biotechnology Industry Organization's (BIO) policy statement...
May 13 1997
WASHINGTON, D.C.,..Carl Feldbaum, president of the Biotechnology Industry Organization (BIO) will be a key speaker at a Texas panel that will discuss...
Feb 23 1997
(WASHINGTON, DC, February 23, 1997) . . . Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
Feb 1 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has called for strong protections against the misuse of personal medical information...


Biotechnology News

July 31, 2014

OSAKA, Japan--(BUSINESS WIRE)--Panasonic Healthcare to propose unique solutions that take advantage of its medical IT systems to better medical treatment.

July 31, 2014

WASHINGTON--(BUSINESS WIRE)--The Association of Clinical Research Organizations (ACRO) strongly supports the COMPETE Act of 2014 introduced today by Senator Tom Carper (D-...

July 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that management will present a...

July 31, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it will host two seminars at the Dioxin 2014 International Symposium in Madrid,...

July 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report second quarter 2014 financial...